The study of rice bran oil emulsions beverage intervention on inflammation status among metabolic syndrome adult subjects

The inhibition of the oxidation reaction through dietary therapy is expected to prevent from the emergence of metabolic disorder e.g. obesity-related complications, insulin resistance, and dyslipidemia. One of the food commodities that can be utilized is rice bran due to oryzanol content. The objective of this study was to analyze the effect ofintervention ofricebran oil (RBO) emulsionbeverageon inflammatory biomarkersof High SensitivityC-Reactive Protein (HsCRP) and Interleukin-6(IL-6) among metabolic syndrome (MS) adult subjects. This study used a randomized single blind controlled trial design. Thirty five adult subjects (age 34-57 years) with MS are divided into 2 groups. Treatmentgroup (n=18) was givenRBO emulsion beveragefor 4 weeks. The controlgroup (n=17) wasgiven placebo emulsion beverage (withoutRBO). Nutrition intake wasassessedby 24 hours recalls method everyweek. HsCRPand IL-6 levelswere analyzed at pre and postintervention. After4weeks intervention, there was a significant change of theHsCRPlevel (p<0.05) in both groups, while for IL-6 serum levels a significant change only in control groups. However, the level of HsCRPand IL-6 serumin the treatment group no significant difference (p>0.05). The intervention ofrice bran oilseems give benefit for inflammation state on MS subject.